At Griffin Technology we take pride in what we do. Coatings are much more than a process; it's also an art form. With this in mind Griffin was founded on the principles of attention to detail, integrity, honesty, and knowledge and through the pursuit of excellence as custom coaters, we have become the trusted go-to supplier to Metal Fabricators.
At Matera Technologies Inc. we provide a unique manufacturer's rep service. We are a small , defined focus firm that specializes in electro mechanical, passive & interconnect components from a select group of US based manufacturers, representing them to a variety of Canadian OEMs.
Since 1985 Funshine Centre has worked with governments and other agencies to help in providing clothing and shelter for those who are on the street. Meals on wheels for seniors. Awards for high school excellence.Since 1985, we have raised over 1 million with our partners that we have returned back to our communities that we serve.Funshine helps from the street through the criminal justice system and social assistance programs. We also help them with life skills to reintergrate back into society as a positive contrabutor to our community rather then a person without hope sleeping on the street.Funshine works with community groups to help them establish themselves and express a point of view which will open a dialogue in developing social justices. These group are chosen not that they hold the view of Funshine, but that they have a point of view that needs to be heard to create a multi cultural and just society.
CHX Technologies has developed Prevora, a topical pharmaceutical treatment which is a new standard of preventive dental care for the aging population. CHX is marketing Prevora using social media networks and a new point-of-purchase and point-of-advocacy group of dental teams called Partners in Prevention. The current marketing focus is Canada.Prevora is remarkably safe and effective for long periods. It is approved in Canada, Ireland, the United Kingdom and by the European Medicines Agency. A new drug application is being prepared for Germany and the United States.